Proton Therapy Publication
March 2024
Evidence for external beam radiotherapy in mediastinal Hodgkin and non-Hodgkin lymphoma - systematic review.
Link to the fully detailed content
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
Link to the fully detailed content
Proton Therapy Publication
December 2022
Proton and Carbon Ion Radiotherapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Dose in Non-small Cell Lung Cancer versus Intensity Modulated Radiotherapy.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
October 2022
Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
August 2021
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma
Link to the fully detailed content
Proton Therapy Publication
June 20221
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
April 2021
Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma
Link to the fully detailed content
Proton Therapy Publication
January 2021
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory lymphoma: A PTCOG and PCG Collaboration.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
December 2020
FLASH Investigations Using Protons: Design of Delivery System, Preclinical Setup and Confirmation of FLASH Effect with Protons in AnimalSystems.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
July 2020
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies.
Link to the fully detailed content